SCHEMBL6227964

SCHEMBL6227964

[2H]C1=CC2=CC3=NC(=CC4=NC(=CC5=NC(=CC1=N2)C=C5)C=C4I)C=C3I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1603958 0.80 — —
SCHEMBL1603047 0.80 — —
SCHEMBL1602933 0.80 — —
SCHEMBL1603317 0.80 — —
SCHEMBL1603252 0.80 — —
SCHEMBL1603253 0.80 — —
SCHEMBL1603263 0.80 — —
SCHEMBL1603345 0.80 — —
SCHEMBL6227475 0.79 — —
Hydrochloric Acid SCHEMBL6227562 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137180-A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2005-06-23 — — US claimed
EP-1401506-A4 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARM INC (US) 2005-02-16 — — EP claimed
EP-1401506-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY Miravant Pharmaceuticals, Inc. (US) 2004-03-31 — — EP claimed
US-20030105069-A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2003-06-05 — — US claimed
WO-2002096366-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARMACEUTICALS, INC. (US) 2002-12-05 — — WO claimed
Send feedback